Clinical trials: PET/CT Imaging
Prostate Cancer
Clinical Study on 68Ga-PSMA-33 for PET/CT Imaging of Prostate Cancer
The purpose of this study is to determine the pharmacokinetics, dosimetry, tolerance, tumor detection rate of 68Ga-PSMA-33 in patient with Prostate Cancer (PCa).
- Trial name
- NCT06054789
- Testing
- 68Ga-PSMA-33
- Where
- China
- Volunteers
- 8 people
- Sponsor
- Nanjing First Hospital, Nanjing Medical University
Stroke
68Ga-BNOTA-PRGD2 PET/CT in Evaluation of Stroke
This is an open-label brain PET/CT (positron emission tomography/computed tomography) study to investigate the diagnostic performance of 68Ga-BNOTA-PRGD2 in evaluation of stroke patients in convalescence.
- Trial name
- GRGDS (NCT01656785)
- Testing
- 68Ga-BNOTA-PRGD2
- Where
- China
- Volunteers
- 50 people
- Sponsor
- Peking Union Medical College Hospital
Metastatic Breast Cancer (HR+/ HER2-)
Predicting Endocrine Resistance Using Molecular Imaging and Liquid Biopsy in Metastatic Breast Cancer
This prospective observational study aims to evaluate the prognostic value of molecular imaging biomarkers derived from baseline [18F]FES and [18F]FDG PET/CT for progression-free survival in patients with estrogen receptor…
- Trial name
- NCT07867925
- Testing
- [18F] FES
- Where
- South Korea
- Volunteers
- 100 people
- Sponsor
- Asan Medical Center
Prostate Cancer
Study of 18F-DCFPyL PET/CT Imaging in Patients With Prostate Cancer
This study evaluates the safety and diagnostic performance of 18F-DCFPyL Injection in patients with at least high risk prostate cancer who are planned for radical prostatectomy with lymphadenectomy (Cohort A) or in patients with…
- Trial name
- OSPREY (NCT02981368)
- Testing
- 18F-DCFPyL Injection, PET/CT imaging
- Where
- 10 sites in United States, Canada
- Volunteers
- 385 people
- Sponsor
- Progenics Pharmaceuticals, Inc.
Kidney Cancer, Lymphomas
A Study of the Clinical Application of [18F]RCCB6 and [68Ga]Ga-NOTA-RCCB6 PET/CT Imaging in the Diagnosis of CD70-expressing Multiple Tumors
The aim of this study was to establish and optimize the [18F]RCCB6 and [68Ga]Ga-NOTA-RCCB6 PET/CT imaging method, and its physiological and pathological distribution characteristics, on the basis of which the diagnostic efficacy…
- Conditions
- Kidney Cancer, Lymphomas, Positron Emission Tomography
- Trial name
- NCT06148220
- Testing
- [18F]RCCB6 and [68Ga]Ga-NOTA-RCCB6 PET/CT imaging
- Where
- China
- Volunteers
- 20 people
- Sponsor
- Huashan Hospital